Full article: Novel multi-target ligands of dopamine and serotonin

Frontiers Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo

Pharmaceutics, Free Full-Text

Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands - ScienceDirect

Update on GPCR-based targets for the development of novel antidepressants

Ligand with Two Modes of Interaction with the Dopamine D2 Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism

Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System: Trends in Neurosciences

Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer

Dopamine D2 receptor antagonists with selective serotonin reuptake

PDF) Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Ligand-directed bias of G protein signaling at the dopamine D2 receptor - ScienceDirect

Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability - ScienceDirect